These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 22221266

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity.
    Barnadas MA, Rubiales MV, Gich I, Gelpí C.
    Int J Dermatol; 2015 Nov; 54(11):1261-8. PubMed ID: 25754029
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
    Mentink LF, de Jong MC, Kloosterhuis GJ, Zuiderveen J, Jonkman MF, Pas HH.
    Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L, Deidda S, Aste N.
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [Abstract] [Full Text] [Related]

  • 11. Correlation of Antibodies against Desmogleins 1 and 3 with Indirect Immunofluorescence and Disease Activity in 72 Patients with Pemphigus Vulgaris.
    Živanović D, Medenica L, Soldatović I, Popadić D.
    Acta Dermatovenerol Croat; 2017 Apr; 25(1):8-14. PubMed ID: 28511744
    [Abstract] [Full Text] [Related]

  • 12. ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.
    Abasq C, Mouquet H, Gilbert D, Tron F, Grassi V, Musette P, Joly P.
    Arch Dermatol; 2009 May; 145(5):529-35. PubMed ID: 19451496
    [Abstract] [Full Text] [Related]

  • 13. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T, Fujii Y, Ishida A, Handa M, Tanikawa A, Amagai M, Nishikawa T.
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [Abstract] [Full Text] [Related]

  • 14. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.
    Ishii K, Amagai M, Hall RP, Hashimoto T, Takayanagi A, Gamou S, Shimizu N, Nishikawa T.
    J Immunol; 1997 Aug 15; 159(4):2010-7. PubMed ID: 9257868
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
    Adaszewska A, Kalinska-Bienias A, Jagielski P, Wozniak K, Kowalewski C.
    J Immunol Methods; 2019 May 15; 468():35-39. PubMed ID: 30910537
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antidesmoglein 1 and 3 antibodies in healthy subjects of a population in the Peruvian high amazon.
    Ramos W, Díaz J, Gutierrez EL, Lazarte JS, Bohnett MC, Ronceros G, Ortega-Loayza AG.
    Int J Dermatol; 2018 Mar 15; 57(3):344-348. PubMed ID: 29130480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.